RxDoctor Payments Data

Katherine Strickland

Family · Gainesville, FLNPI 1639360589

Payments from drug & device makers

$10,411in general payments, 2019–2025

Across 153 payments — averaging $68.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Fresenius USA Marketing, Inc.$7K
  • Vifor Pharma, Inc.$879
  • AstraZeneca$546
  • Amgen$378
  • Sanofi$320
  • Ardelyx, Inc.$236
  • plus $1K from 12 others

What the payments were for

  • Speaking & faculty fees$4,50043%
  • Travel & lodging$9339%
  • Food & beverage$4,78346%
  • Education$1952%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,411 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$15,358
Medicare patients
49
Services billed
186

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VelphoroSucroferric Oxyhydroxide226$561,614
AuryxiaFerric Citrate234$511,120
VeltassaPatiromer Calcium Sorbitex73$97,874
Sevelamer Carbonate295$65,596
LokelmaSodium Zirconium Cyclosilicate25$37,206
RenvelaSevelamer Carbonate14$27,679
Lanthanum Carbonate35$21,202
Clonidine17$3,335
Midodrine Hcl14$2,011
Lidocaine-PrilocaineLidocaine/Prilocaine40$700
Doxazosin Mesylate25$586
Hydralazine Hcl41$579
Amlodipine Besylate89$477
Nifedipine ErNifedipine11$437
Losartan Potassium45$428

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Fresenius USA Marketing, Inc.Velphoro$6,698$561,614226 claims
Akebia Therapeutics IncAuryxia$231$511,120234 claims
AstraZenecaLokelma$546$37,20625 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 14,618 family providers in Florida.

Other family in Gainesville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →